The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
The aim of this study was to prospectively screen patients with a positive family history of carcinoid small intestine neuroendocrine tumors (SI-NETs) to elucidate the benefits of early detection and operative intervention.A single-center, prospective trial was conducted from 2008 to 2014 that evaluated patients with 2 or more blood relatives with carcinoid SI-NETs. All eligible patients were screened...
There are limited data on the utility of 6- 18 F-fluoro-l-3,4-dihydroxyphenylalanine ( 18 F-DOPA) and 18 F-2-deoxy-d-glucose ( 18 F-FDG) in the workup of patients with pancreatic neuroendocrine tumors (PNETs). The aim of our study was to determine the accuracy of 18 F-DOPA and 18 F-FDG to detect PNETs in patients with von Hippel-Lindau disease (vHL)...
Limited data exist concerning the clinical and imaging features that distinguish sporadic from familial paragangliomas (PGLs).Clinical, genetic (succinate dehydrogenase [SDHB] vs no SDHx), and imaging (computed tomography [CT], magnetic resonance imaging, 18 F-fluoro-deoxy-glucose positron emission tomography [ 18 F-FDG-PET]) features obtained during a decade in 124 PGL patients were...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.